GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 1c

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $203.1 million versus the consensus estimate of $205.87 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Increasing unusual put volume: AVGX WMB FJET EWA NASA BSX DFTX ACI TE BURL HSBC RIO WRBY OBDC GT DRAM
• FedEx (FDX) call put ratio 1 call to 2.8 puts with a focus on June 26 weekly 325 puts into quarter results